Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery

Completed · Phase 3 · Has a placebo group

Conditions studied: Deep Vein Thrombosis, Pulmonary Embolism

In brief

The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein Thrombosis \[DVT\]) and lung (pulmonary embolism \[PE\]) that sometimes occur after knee replacement surgery and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied.

Key facts

Study ID
NCT00371683
Run by
Bristol-Myers Squibb
People needed
3608
Starts
2006-11-01
Expected to finish
2008-05-01
Last updated by the study team
2015-12-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.